A Pilot Study of the Value of 18f-Fluoro-Deoxy-Thymidine PET/CT in Predicting Viable Lymphoma in Residual 18f-FDG Avid Masses After Completion of Therapy
Clinical Nuclear Medicine - United States
doi 10.1097/rlu.0000000000000539
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2014
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)